Journal article
Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes
- Abstract:
- The systemic vasculitides are a group of multisystem diseases, which can be life and organ threatening. High-dose immunosuppressants are required to control inflammation in vital organs, such as the kidneys, lungs, skin, joints, and eyes. Patients report a range of impacts on their health-related quality of life due to symptoms, irreversible damage, and the adverse effects of medications. The measurement of patient perspectives within clinical studies in vasculitis is essential to capture outcomes of greatest importance to patients. Validated generic, disease-specific and symptom-specific patient-reported outcomes available for use in patients with systemic vasculitis are reviewed here.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 142.5KB, Terms of use)
-
- Publisher copy:
- 10.2147/PROM.S163601
Authors
- Publisher:
- Dove Press
- Journal:
- Patient Related Outcome Measures More from this journal
- Volume:
- 10
- Pages:
- 37-42
- Publication date:
- 2019-02-08
- Acceptance date:
- 2018-10-26
- DOI:
- ISSN:
-
1179-271X
- Pmid:
-
30804691
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:980528
- UUID:
-
uuid:9e5cda5a-bb22-4dcf-8a4a-6b30ada44936
- Local pid:
-
pubs:980528
- Source identifiers:
-
980528
- Deposit date:
-
2019-04-24
Terms of use
- Copyright holder:
- Robson et al
- Copyright date:
- 2019
- Notes:
- © 2019 Robson et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record